Related Experiment Video
Updated: Mar 6, 2026
13:59
High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds
Published on: August 18, 2023
2.8K
Toxicity Management: Development of a Novel and Immune-Mediated Adverse Events Algorithm
Haleigh Mistry1, Sheryl G Forbes1, Nathan Fowler1
1University of Texas MD Anderson Cancer Center.
Clinical Journal of Oncology Nursing
|March 19, 2017
Summary
A new algorithm helps manage unique toxicities from novel immunotherapies in blood cancer patients. This approach improves safety, outcomes, and quality of life for those receiving these advanced treatments.
Area of Science:
- Hematologic Oncology
- Immunotherapy
- Drug Development
Background:
- Novel immunotherapy and biologic agents show promise for hematologic malignancies.
- These agents can cause unique immune-mediated toxicities due to their effects on neoplastic cells and the microenvironment.
Purpose of the Study:
- To develop a system-focused algorithm for clinical staff to manage unique toxicities.
- To address the management of toxicities associated with next-generation immunotherapies in hematologic patients.
Main Methods:
- Data collection focused on specific toxicities across four major novel biologic classes.
- Immune-mediated adverse events were reviewed from published literature and institutional experience.
- A consensus-based algorithm was created for managing immune-mediated toxicities.
Main Results:
- The developed treatment algorithm offers a streamlined approach to managing unique toxicities.
- Implementation of the algorithm is expected to improve safety and patient compliance.
- Enhanced patient outcomes and quality of life are anticipated with novel immuno-oncologic agents.
Conclusions:
- The novel algorithm provides a structured method for managing immune-mediated toxicities in hematologic malignancies.
- This approach enhances the safe and effective use of emerging immunotherapies.
- Improved patient outcomes and quality of life are key benefits of this management strategy.
More Related Videos
07:50Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish
Published on: July 16, 2012
14.8K
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
1.9K
Related Concept Videos
01:19Pharmacovigilance
1.9K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.9K
01:30Drug Toxicity: Allergic Reactions
75
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
75
01:00Drug Toxicity: Overview
101
Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
101
01:16Drug toxicity: Idiosyncratic Reactions
75
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
75
01:26Pharmaceutical Poisoning: Potential Scenarios
47
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
47
01:24Drug Toxicity: Risk factors
65
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
65